Kelly P Burke

7PUBLICATIONS
98CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 13, 2026
Stability and progressive differentiation of TFR cells are intrinsically and extrinsically controlled by TFH programs.

Jeong-Mi Lee, Paulo Lisboa Raeder, Ridwan B Rashid

|Sep 01, 2025
Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanoma.

Jiekun Yang, Cassia Wang, Doris Fu

|Jul 24, 2025
PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashion.

Kristen E Pauken, Samuel C Markson, Thomas S Conway

|Dec 07, 2023
PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients.

Thomas Denize, Opeyemi A Jegede, Sayed Matar

|Jan 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial.

Jun Tian, Jonathan H Chen, Sherry X Chao

|Apr 13, 2022
When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer.

Mohamed S Hasim, Marie Marotel, Jonathan J Hodgins

Pageof 2

Frequent Collaborators

5 joint publications

Arlene Sharpe

2 joint publications

Marcia C Haigis

2 joint publications

Gordon J Freeman

1 joint publications

Peter T Sage